Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease
- 1 January 1990
- journal article
- Published by Elsevier BV in Bone and Mineral
- Vol. 8 (1), 87-96
- https://doi.org/10.1016/0169-6009(91)90143-n
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Evidence that free gamma carboxyglutamic acid circulates in serumClinica Chimica Acta; International Journal of Clinical Chemistry, 1989
- Measurement of the cross linking compound, pyridinoline, in urine as an index of collagen degradation in joint disease.Annals Of The Rheumatic Diseases, 1986
- CROSS-LINKING IN COLLAGEN AND ELASTINAnnual Review of Biochemistry, 1984
- Aging and cross-linking in human aortaBiochemical and Biophysical Research Communications, 1982
- TREATMENT OF PAGET'S DISEASE WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- Urinary excretion of hydroxyproline, hydroxylysine and hydroxylysine glycosides by patients with paget's disease of bone and carcinoma with metastases in boneClinica Chimica Acta; International Journal of Clinical Chemistry, 1979
- Pro—Gln: The procollagen peptidase cleavage site in the α1 (I) chain of dermatosparactic calf skin procollagenFEBS Letters, 1978
- Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation.JCI Insight, 1977
- LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN: EVIDENCE FOR AN INCREASED BONE MASS AFTER DELAYED ONSET OF ŒSTROGEN TREATMENTThe Lancet, 1976
- Isotopic Studies on Collagen Degradation and the Urine Excretion of Hydroxyproline *JCI Insight, 1964